Weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC): Preliminary results of a phase study.

被引：0
|
作者：
Jiang, Youhua
Yun, Fan
Chen, Qixun
Zhou, Xinming
Huang, Zhiyu
Gong, Lei
Yang, Haiyan
Yu, Haifeng
Liu, Jinshi
Chen, Pengcheng
Zhao, Qiang
Mao, Weimin
机构：
[1] Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Canc Hosp, Key Lab Diag & Treatment Technol Thorac Oncol, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Canc Hosp, Canc Res Inst, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15062
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC).
    Yun, Fan
    Zhou, Xinming
    Jiang, Youhua
    Chen, Qixun
    Huang, Zhiyu
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Liu, Jinshi
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [2] Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma
    Fan, Yun
    Jiang, Youhua
    Zhou, Xinming
    Chen, Qixun
    Huang, Zhiyu
    Xu, Yanjun
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Liu, Jinshi
    Lei, Tao
    Zhao, Qiang
    Mao, Weimin
    ONCOTARGET, 2016, 7 (31) : 50624 - 50634
  • [3] Clinical outcomes following neoadjuvant nab-paclitaxel and cisplatin chemotherapy for locally advanced esophageal squamous cell carcinoma.
    Yun, Fan
    Hua, Jiang You
    Min, Zhou Xin
    Xun, Chen Qi
    Yu, Huang Zhi
    Lei, Gong
    Yuan, Yang Hai
    Shi, Liu Jin
    Chen, Chen Peng
    Qiang, Zhao
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Survival outcomes in patients with locally advanced esophageal squamouscell carcinoma treated with nab-paclitaxel and cisplatin as neoadjuvant chemotherapy
    Yun, F.
    Jiang-, Y.
    Chen, Q.
    Zhou, X.
    Huang, Z.
    Mao, W.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S411 - S412
  • [5] Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Zhao, Jidong
    He, Ming
    Li, Jie
    Li, Dan
    Zhao, Yang
    Li, Xinhui
    Zhang, Xiangmei
    Chen, Xin
    Liu, Yunjiang
    Zhao, Liyan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (04) : 324 - 331
  • [6] Neoadjuvant pembrolizumab/nab-paclitaxel/cisplatin in patients with locally advanced head and neck squamous cell carcinoma: A single-arm phase II study
    Zhang, Siyi
    Ma, Haiqing
    Zhan, Jiandong
    Zhu, Lijun
    Zhang, Hong-Dan
    Du, Shasha
    Dong, Qiumei
    Wang, Guangyi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] NEOADJUVANT CAMRELIZUMAB IN COMBINATION WITH ALBUMIN PACLITAXEL AND CISPLATIN FOR PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
    Lv, Huilai
    Tian, Yang
    Li, Zhenhua
    Huang, Chao
    Xu, Yanzhao
    Tian, Ziqiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A587 - A587
  • [8] Chemoradiotherapy Combined with Nab-Paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Study
    Yu, N.
    Li, J.
    Chen, X.
    Wang, Z.
    Kang, X.
    Zhang, R.
    Qin, J.
    Zheng, Q.
    Feng, G.
    Deng, L.
    Zhang, T.
    Wang, W.
    Liu, W., Jr.
    Wang, J.
    Feng, Q.
    Lv, J.
    Chen, D.
    Zhou, Z.
    Xiao, Z.
    Li, Y.
    Bi, N.
    Li, Y.
    Wang, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E354 - E354
  • [9] A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma
    Naru Kondo
    Yoshiaki Murakami
    Kenichiro Uemura
    Takeshi Sudo
    Yasushi Hashimoto
    Naoya Nakagawa
    Shinya Takahashi
    Hiroki Ohge
    Taijiro Sueda
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 775 - 781
  • [10] A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakagawa, Naoya
    Takahashi, Shinya
    Ohge, Hiroki
    Sueda, Taijiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 775 - 781
12345